CrossrefInfokarte
Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
International Journal of Dermatology · 2026-12 · 65 (12) · 2581-2583
DOI: 10.1111/ijd.70460 ↗Abstract
Kein Abstract verfügbar.
EUVIMED